V Waters

Summary

Affiliation: The Hospital for Sick Children
Country: Canada

Publications

  1. ncbi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Cochrane Database Syst Rev 12:CD010004. 2014
  2. ncbi request reprint Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 12:482-6. 2013
  3. ncbi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 12:CD010004. 2012
  4. ncbi request reprint Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 11:CD009528. 2012
  5. ncbi request reprint Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    V Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
    Eur J Clin Microbiol Infect Dis 31:3341-50. 2012
  6. ncbi request reprint Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Eur Respir J 40:61-6. 2012
  7. ncbi request reprint Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 11:8-13. 2012
  8. ncbi request reprint New treatments for emerging cystic fibrosis pathogens other than Pseudomonas
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada
    Curr Pharm Des 18:696-725. 2012
  9. ncbi request reprint Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
    Am J Respir Crit Care Med 183:635-40. 2011
  10. ncbi request reprint Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    Pediatr Infect Dis J 28:582-7. 2009

Detail Information

Publications11

  1. ncbi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Cochrane Database Syst Rev 12:CD010004. 2014
    ....
  2. ncbi request reprint Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 12:482-6. 2013
    ..The goal of this study was to determine the effect of chronic S. maltophilia infection on mortality and the need for lung transplantation in a longitudinal study of children and adults with CF...
  3. ncbi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 12:CD010004. 2012
    ....
  4. ncbi request reprint Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 11:CD009528. 2012
    ..Therefore, choosing antibiotics based on biofilm rather than conventional antimicrobial susceptibility testing could potentially improve response to treatment of Pseudomonas aeruginosa in people with cystic fibrosis...
  5. ncbi request reprint Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    V Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
    Eur J Clin Microbiol Infect Dis 31:3341-50. 2012
    ..aeruginosa isolates from CF patients. MLST had the greatest predictive value in identifying strains as unique and, thus, has the potential to be a cost-efficient, high-throughput, first-pass typing method...
  6. ncbi request reprint Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Eur Respir J 40:61-6. 2012
    ..Time between exacerbations, specifically ≤ 6 months between exacerbations, plays an important contribution to overall lung function decline. These findings support using time to next exacerbation as a clinical end-point for CF trials...
  7. ncbi request reprint Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 11:8-13. 2012
    ..The aim of this study was to determine the effect of chronic S. maltophilia infection and associated antimicrobial therapy on the recovery of forced expiratory lung volume in 1s (FEV(1)) following pulmonary exacerbation...
  8. ncbi request reprint New treatments for emerging cystic fibrosis pathogens other than Pseudomonas
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada
    Curr Pharm Des 18:696-725. 2012
    ....
  9. ncbi request reprint Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
    Am J Respir Crit Care Med 183:635-40. 2011
    ..maltophilia infection on CF lung disease is unknown...
  10. ncbi request reprint Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    Pediatr Infect Dis J 28:582-7. 2009
    ..A case-control study in children was done to identify the risk factors for being positive for Bordetella pertussis by polymerase chain reaction (PCR)...
  11. pmc Live viral vaccines in a DiGeorge syndrome patient
    V Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, Canada
    Arch Dis Child 92:519-20. 2007
    ..Although live viral vaccines have been used safely in some children with DiGeorge syndrome, there are insufficient data to recommend their routine use in those with severe immunodeficiency...